Physiological and Metabolic Changes During the Transition from Hyperthyroidism to Euthyroidism in Graves' Disease

被引:56
作者
Chng, Chiaw-Ling [1 ]
Lim, Adoree Yi Ying [1 ]
Tan, Hong Chang [1 ]
Kovalik, Jean-Paul [3 ]
Tham, Kwang Wei [1 ]
Bee, Yong Mong [1 ]
Lim, Weiying [1 ]
Acharyya, Sanchalika [4 ]
Lai, Oi Fah [2 ]
Chong, Mary Foong-Fong [5 ]
Yen, Paul Michael [3 ]
机构
[1] Singapore Gen Hosp, Dept Endocrinol, Level 3,20 Coll Rd, Singapore 169856, Singapore
[2] Singapore Gen Hosp, Dept Clin Res, Singapore, Singapore
[3] Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore
[4] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore
[5] ASTAR, Brenner Ctr Mol Med, SICS, Singapore, Singapore
关键词
THYROID-HORMONE ACTION; INSULIN-RESISTANCE; SERUM CONCENTRATIONS; INDIRECT CALORIMETRY; SKELETAL-MUSCLE; WEIGHT-GAIN; L-CARNITINE; GLUCOSE; ADIPONECTIN; DYSFUNCTION;
D O I
10.1089/thy.2015.0602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The serum metabolomic profile and its relationship to physiological changes during hyperthyroidism and restoration to euthyroidism are not known. This study aimed to examine the physiological, adipokine, and metabolomic changes that occur when subjects with Graves' disease transition from hyperthyroidism to euthyroidism with medical treatment. Methods: Chinese women between 21 and 50 years of age and with newly diagnosed Graves' disease attending the endocrine outpatient clinics in a single institution were recruited between July 2012 and September 2014. All subjects were treated with thioamides to achieve euthyroidism. Clinical parameters (body weight, body composition via bioelectrical impedance analysis, resting energy expenditure and respiratory quotient via indirect calorimetry, and reported total energy intake via 24h food diary), biochemical parameters (thyroid hormones, lipid profile, fasting insulin and glucose levels), serum leptin, adiponectin, and metabolomics profiles were measured during hyperthyroidism and repeated in early euthyroidism. Results: Twenty four Chinese women with an average age of 36.38.6 years were included in the study. The average duration of treatment that was required to reach euthyroidism for these subjects was 38 +/- 16.3 weeks. There was a significant increase in body weight (52.6 +/- 9.0kg to 55.3 +/- 9.4kg; p<0.001) and fat mass (14.3 +/- 6.9kg to 16.8 +/- 6.5kg; p=0.005). There was a reduction in resting energy expenditure corrected for weight (28.7 +/- 4.0kcal/kg to 21.5 +/- 4.1kcal/kg; p<0.001) and an increase in respiratory quotient (0.76 to 0.81; p=0.037). Resting energy expenditure increased significantly with increasing free triiodothyronine levels (p=0.007). Significant increases in total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol were noted. There was no significant change in leptin levels, but adiponectin levels increased significantly (p=0.018). Significant reductions in fasting C2, medium-chain, long-chain, and total acylcarnitines were observed, but no changes in the fat-free mass, branched chain amino acid levels, or insulin sensitivity during recovery from hyperthyroidism were noted. Conclusions: Serum metabolomics profile changes complemented the physiological changes observed during the transition from hyperthyroidism to euthyroidism. This study provides a comprehensive and integrated view of the changes in fuel metabolism and energy balance that occur following the treatment of hyperthyroidism.
引用
收藏
页码:1422 / 1430
页数:9
相关论文
共 46 条
[1]   Estimating body fat and lean tissue distribution in hyperthyroidism by dual-energy X-ray absorptiometry [J].
Acotto, CG ;
Niepomniszcze, H ;
Mautalen, CA .
JOURNAL OF CLINICAL DENSITOMETRY, 2002, 5 (03) :305-311
[2]   Effects of carnitine on thyroid hormone action [J].
Benvenga, S ;
Amato, A ;
Calvani, M ;
Trimarchi, F .
CARNITINE: THE SCIENCE BEHIND A CONDITIONALLY ESSENTIAL NUTRIENT, 2004, 1033 :158-167
[3]   Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: A randomized. double-blind, placebo-controlled clinical trial [J].
Benvenga, S ;
Ruggeri, RM ;
Russo, A ;
Lapa, D ;
Campenni, A ;
Trimarchi, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3579-3594
[4]   Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients [J].
Brokken, LJS ;
Wiersinga, WM ;
Prummel, MF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09) :4135-4138
[5]  
Brunova J, 2003, SAMJ S AFR MED J, V93, P529
[6]   L-carnitine treatment in a seriously ill cancer patient with severe hyperthyroidism [J].
Chee R. ;
Agah R. ;
Vita R. ;
Benvenga S. .
Hormones, 2014, 13 (3) :407-412
[7]   Hyperthyroidism-Associated Insulin Resistance Is Not Mediated by Adiponectin Levels [J].
Chu, Chih-Hsun ;
Lam, Hing-Chung ;
Lee, Jenn-Kuen ;
Lu, Chih-Chen ;
Sun, Chun-Chin ;
Wang, Mei-Chun ;
Chuang, Ming-Ju .
JOURNAL OF THYROID RESEARCH, 2011, 2011
[8]   Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients [J].
Chung, Yun Jae ;
Lee, Byung Wan ;
Kim, Ji-Youn ;
Jung, Jung Hwa ;
Min, Yong-Ki ;
Lee, Myung-Shik ;
Lee, Moon-Kyu ;
Kim, Kwang-Won ;
Chung, Jae Hoon .
THYROID, 2006, 16 (12) :1251-1257
[9]   Effectiveness of the US Department of Agriculture 5-step multiple-pass method in assessing food intake in obese and nonobese women [J].
Conway, JM ;
Ingwersen, LA ;
Vinyard, BT ;
Moshfegh, AJ .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2003, 77 (05) :1171-1178
[10]   Links between thyroid hormone action, oxidative metabolism, and diabetes risk? [J].
Crunkhorn, Sarah ;
Patti, Mary-Elizabeth .
THYROID, 2008, 18 (02) :227-237